{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:07:45Z","timestamp":1792080465055,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-03039-x","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:22:28Z","timestamp":1762338148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of advanced fibrosis risk using FIB-4 in patients with type 2 diabetes and its associated factors: a cross-sectional study in a primary care unit of a university hospital in Southern Thailand"],"prefix":"10.1186","volume":"26","author":[{"given":"Thareerat","family":"Ananchaisarp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panya","family":"Chamroonkiadtikun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Bunchote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraphat","family":"Thedpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonnikan","family":"Srisamoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuda","family":"Rujiworanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vissut","family":"Jayasakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsurang","family":"Chaiphom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaphum","family":"Kittivarapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuthprawee","family":"Chuaysong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimsiri","family":"Sripongpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"3039_CR1","unstructured":"International Diabetes Federation, Diabetes Atlas IDF. 2021 Available from: https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/. Cited 2025 Januuary 30."},{"issue":"4","key":"3039_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.33192\/smj.v76i4.267556","volume":"76","author":"A Kaewdech","year":"2024","unstructured":"Kaewdech A, Sripongpun P. Navigating the nomenclature of liver steatosis: transitioning from NAFLD to MAFLD and MASLD - Understanding affinities and differences. Siriraj Med J. 2024;76(4):234\u201343. https:\/\/doi.org\/10.33192\/smj.v76i4.267556.","journal-title":"Siriraj Med J"},{"issue":"3","key":"3039_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.20524\/aog.2021.0604","volume":"34","author":"E Cholongitas","year":"2021","unstructured":"Cholongitas E, Pavlopoulou I, Papatheodoridi M, Markakis GE, Bouras E, Haidich AB, et al. Epidemiology of nonalcoholic fatty liver disease in europe: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34(3):404\u201314. https:\/\/doi.org\/10.20524\/aog.2021.0604.","journal-title":"Ann Gastroenterol"},{"key":"3039_CR4","first-page":"205","volume":"57","author":"M Prashanth","year":"2009","unstructured":"Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India. 2009;57:205\u201310.","journal-title":"J Assoc Physicians India"},{"key":"3039_CR5","first-page":"S93","volume":"101","author":"Prevalence","year":"2018","unstructured":"Prevalence. Risk factors of Non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with normal serum aminotransferase levels. J Med Assoc Thai. 2018;101:S93\u2013103. [Suppl.4].","journal-title":"J Med Assoc Thai"},{"issue":"11","key":"3039_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):645\u2013. https:\/\/doi.org\/10.1038\/nrgastro.2013.182. 55.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"3039_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10620-021-06955-x","volume":"67","author":"N Noureddin","year":"2022","unstructured":"Noureddin N, Noureddin M, Singh A, Alkhouri N. Progression of nonalcoholic fatty liver Disease-Associated fibrosis in a large cohort of patients with type 2 diabetes. Dig Dis Sci. 2022;67(4):1379\u201388. https:\/\/doi.org\/10.1007\/s10620-021-06955-x.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3039_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/hep.32545","volume":"77","author":"P Sripongpun","year":"2023","unstructured":"Sripongpun P, Kim WR, Mannalithara A, Charu V, Vidovszky A, Asch S, et al. The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care. Hepatol Baltim Md. 2023;77(1):256\u201367. https:\/\/doi.org\/10.1002\/hep.32545.","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"3039_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4158\/EP-2019-0342","volume":"26","author":"H Bian","year":"2020","unstructured":"Bian H, Zhu X, Xia M, Yan H, Chang X, Hu X, et al. Impact of type 2 diabetes on nonalcoholic steatohepatitis and advanced fibrosis in patients in patients with nonalcoholic fatty liver disease. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2020;26(4):444\u201353. https:\/\/doi.org\/10.4158\/EP-2019-0342.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"2","key":"3039_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco R, Godinez Leiva E, Bril F, Shrestha S, Mansour L, Budd J, et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening. Diabetes Care. 2021;44(2):399\u2013406. https:\/\/doi.org\/10.2337\/dc20-1997.","journal-title":"Diabetes Care"},{"issue":"17","key":"3039_CR11","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385(17):1559\u201369. https:\/\/doi.org\/10.1056\/NEJMoa2029349.","journal-title":"N Engl J Med"},{"issue":"7","key":"3039_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.045232","volume":"172","author":"LA Adams","year":"2005","unstructured":"Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ Can Med Assoc J J Assoc Medicale Can. 2005;172(7):899\u2013905. https:\/\/doi.org\/10.1503\/cmaj.045232.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"8","key":"3039_CR13","doi-asserted-by":"publisher","first-page":"e17622","DOI":"10.7759\/cureus.17622","volume":"13","author":"B Kumari","year":"2021","unstructured":"Kumari B, Kumar R, Sharma S, Banerjee A, Kumar V, Kumar P, et al. Diagnostic accuracy of FIB-4 and FIB-5 scores as compared to fibroscan for assessment of liver fibrosis in patients with Non-Alcoholic fatty liver disease. Cureus. 2021;13(8):e17622. https:\/\/doi.org\/10.7759\/cureus.17622.","journal-title":"Cureus"},{"key":"3039_CR14","doi-asserted-by":"publisher","first-page":"1172178","DOI":"10.3389\/fcvm.2023.1172178","volume":"10","author":"L Guan","year":"2023","unstructured":"Guan L, Li L, Zou Y, Zhong J, Qiu L. Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999\u20132008. Front Cardiovasc Med. 2023;10:1172178. https:\/\/doi.org\/10.3389\/fcvm.2023.1172178.","journal-title":"Front Cardiovasc Med"},{"key":"3039_CR15","unstructured":"The American Diabetes Association Releases the Standards of Care in Diabetes. 2024. Available from: https:\/\/diabetes.org\/newsroom\/press-releases\/american-diabetes-association-releases-standards-care-diabetes-2024. Cited 2024 Apr 5."},{"issue":"1","key":"3039_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s13340-020-00453-7","volume":"12","author":"N Kawata","year":"2020","unstructured":"Kawata N, Takahashi H, Iwane S, Inoue K, Kojima M, Kohno M, et al. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients. Diabetol Int. 2020;12(1):118\u201325. https:\/\/doi.org\/10.1007\/s13340-020-00453-7.","journal-title":"Diabetol Int"},{"issue":"4","key":"3039_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/biomedicines12040823","volume":"12","author":"DS Karagiannakis","year":"2024","unstructured":"Karagiannakis DS, Stefanaki K, Petrea F, Zacharaki P, Giannou A, Michalopoulou O, et al. Elevated FIB-4 is associated with higher rates of cardiovascular disease and extrahepatic cancer history in patients with type 2 diabetes mellitus. Biomedicines. 2024;12(4):823. https:\/\/doi.org\/10.3390\/biomedicines12040823.","journal-title":"Biomedicines"},{"issue":"4","key":"3039_CR18","doi-asserted-by":"publisher","first-page":"102536","DOI":"10.1016\/j.jceh.2025.102536","volume":"15","author":"FD Mart\u00ednez-S\u00e1nchez","year":"2025","unstructured":"Mart\u00ednez-S\u00e1nchez FD, Corredor-Nassar MJ, Feria-Agudelo SM, Paz-Zarza VM, Martinez-Perez C, Diaz-Jarquin A, et al. Factors associated with advanced liver fibrosis in a population with type 2 diabetes: A multicentric study in Mexico City. J Clin Exp Hepatol. 2025;15(4):102536. https:\/\/doi.org\/10.1016\/j.jceh.2025.102536.","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"3039_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.59556\/japi.72.0582","volume":"72","author":"V Panikar","year":"2024","unstructured":"Panikar V, Gupta A, Nasikkar N, Joshi S, Walwalkar S, Sachdev I, et al. Prevalence and association of risk factors according to liver steatosis and fibrosis stages among nonalcoholic fatty liver disease patients with type 2 diabetes mellitus in india: A Cross-sectional study. J Assoc Physicians India. 2024;72(7):29\u201333. https:\/\/doi.org\/10.59556\/japi.72.0582.","journal-title":"J Assoc Physicians India"},{"key":"3039_CR20","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-S\u00e1nchez N, Cerda-Reyes E, Higuera-de-la-Tijera F, Salas-Garc\u00eda AK, Cabrera-Palma S, Cabrera-\u00c1lvarez G et al. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis, 2020. Available from: https:\/\/f1000research.com\/articles\/9-56. Cited 2022 Jul 5.","DOI":"10.12688\/f1000research.21918.1"},{"issue":"6","key":"3039_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatol Baltim Md. 2006;43(6):1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"3039_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD). European association for the study of obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"issue":"5","key":"3039_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatol Baltim Md. 2023;77(5):1797\u2013835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323.","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"3039_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.32739","volume":"77","author":"P Udompap","year":"2023","unstructured":"Udompap P, Therneau TM, Canning RE, Benson JT, Allen AM. Performance of American gastroenterological association clinical care pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population. Hepatol Baltim Md. 2023;77(3):931\u201341. https:\/\/doi.org\/10.1002\/hep.32739.","journal-title":"Hepatol Baltim Md"},{"key":"3039_CR25","unstructured":"The American Diabetes Association Releases Standards of Care in Diabetes\u20142025. Available from: https:\/\/diabetes.org\/newsroom\/press-releases\/american-diabetes-association-releases-standards-care-diabetes-2025. Cited 2025 June 5."},{"issue":"10","key":"3039_CR26","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4158\/CS-2020-0490","volume":"26","author":"Y Handelsman","year":"2020","unstructured":"Handelsman Y, Jellinger PS, Guerin CK, Bloomgarden ZT, Brinton EA, Budoff MJ, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the management of dyslipidemia and prevention of cardiovascular disease Algorithm \u2013 2020 executive summary. Endocr Pract. 2020;26(10):1196\u2013224. https:\/\/doi.org\/10.4158\/CS-2020-0490. 2024 Mar 5.","journal-title":"Endocr Pract"},{"key":"3039_CR27","unstructured":"Diabetes Association of Thailand. Clinical Practice Guideline for Diabetes. 2023. Available from: https:\/\/www.dmthai.org\/new\/index.php\/sara-khwam-ru\/bukhlakr-thangkar-phaethy\/cpg\/naewthang-wech-ptibati-sahrab-rokh-bea-hwan-2567. Cited."},{"issue":"1","key":"3039_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"issue":"1","key":"3039_CR29","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1038\/s41598-024-62549-3","volume":"14","author":"D Ouzan","year":"2024","unstructured":"Ouzan D, Penaranda G, Jlaiel M, Joly H, Corneille J. Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease. Sci Rep. 2024;14(1):12198. https:\/\/doi.org\/10.1038\/s41598-024-62549-3.","journal-title":"Sci Rep"},{"issue":"5","key":"3039_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1210\/clinem\/dgac660","volume":"108","author":"S Kalavalapalli","year":"2023","unstructured":"Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, et al. Adipose tissue insulin resistance predicts the severity of liver fibrosis in patients with type 2 diabetes and NAFLD. J Clin Endocrinol Metab. 2023;108(5):1192\u2013201. https:\/\/doi.org\/10.1210\/clinem\/dgac660.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3039_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10238-013-0262-5","volume":"14","author":"L Chrostek","year":"2014","unstructured":"Chrostek L, Supronowicz L, Panasiuk A, Cylwik B, Gruszewska E, Flisiak R. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins. Clin Exp Med. 2014;14(4):417\u201321. https:\/\/doi.org\/10.1007\/s10238-013-0262-5.","journal-title":"Clin Exp Med"},{"issue":"1","key":"3039_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10620-017-4862-x","volume":"63","author":"G Privitera","year":"2018","unstructured":"Privitera G, Spadaro L, Marchisello S, Fede G, Purrello F. Abnormalities of lipoprotein levels in liver cirrhosis: clinical relevance. Dig Dis Sci. 2018;63(1):16\u201326. https:\/\/doi.org\/10.1007\/s10620-017-4862-x.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3039_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatol Baltim Md. 2007;45(4):846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"3039_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/liv.15718","volume":"44","author":"G Li","year":"2024","unstructured":"Li G, Lin H, Sripongpun P, Liang LY, Zhang X, Wong VWS, et al. Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease. Liver Int Off J Int Assoc Study Liver. 2024;44(1):15\u201326. https:\/\/doi.org\/10.1111\/liv.15718.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"12","key":"3039_CR35","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.cgh.2024.06.003","volume":"22","author":"A Kaewdech","year":"2024","unstructured":"Kaewdech A, Sripongpun P, Treeprasertsuk S, Charatcharoenwitthaya P, Chan WK, GO ASIA Study Group. Sequential SAFE score and transient elastography for detecting significant fibrosis in Asian patients with MASLD. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2024;22(12):2535\u20137. https:\/\/doi.org\/10.1016\/j.cgh.2024.06.003.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"1","key":"3039_CR36","doi-asserted-by":"publisher","first-page":"21429","DOI":"10.1038\/s41598-025-06874-1","volume":"15","author":"S Sono","year":"2025","unstructured":"Sono S, Kaewdech A, Wongsawanon C, Varanuntakul T, Jarupanich T, Sritanabutr N, et al. Metabolic dysfunction-associated fatty liver disease (MAFLD) in the adult population attending a health check-up program in thailand: prevalence and fibrosis status. Sci Rep. 2025;15(1):21429. https:\/\/doi.org\/10.1038\/s41598-025-06874-1.","journal-title":"Sci Rep"},{"issue":"6","key":"3039_CR37","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/nu15061501","volume":"15","author":"J Lee","year":"2023","unstructured":"Lee J, Jo G, Park D, Jun HJ, Bae JH, Shin MJ. The association between advanced liver fibrosis and mortality is modified by dietary quality among Korean adults: results from the Korea National health and nutrition examination survey with mortality data. Nutrients. 2023;15(6):1501. https:\/\/doi.org\/10.3390\/nu15061501.","journal-title":"Nutrients"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-03039-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:22:30Z","timestamp":1762338150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-03039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-03039-x","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Office of the Human Research Ethics Committee (HREC) of Faculty of Medicine, Prince of Songkla University (REC 67-599-9-1). Informed consent was not required due to the retrospective design based on medical record review, and a waiver of consent was granted by HREC. Patient confidentiality was maintained by anonymizing all collected data, and findings were reported in aggregate. This manuscript was prepared in accordance with the STROBE guidelines for cross-sectional studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}